Junxiao Hu

8PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data.

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Aug 08, 2024
The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.

Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post

|Jul 24, 2024
Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer.

Jacob B Leary, Junxiao Hu, Alexis Leal

|May 25, 2024
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.

Corbin J Eule, Junxiao Hu, Dale Hedges

|Dec 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers.

Joseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson

Pageof 2

Frequent Collaborators

3 joint publications

Matthew J Sikora

3 joint publications

Benjamin G Bitler

2 joint publications

Sunnie S Kim

2 joint publications

Christopher H Lieu